🔎 Trials Near Me

Akèy › Leksemi limfoblastik egi › Illinois › Chicago

Etid klinik pou Leksemi limfoblastik egi nan Chicago, IL

19 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Ap rekriteFaz 1/2
  • The University of Chicago Medical Center, Chicago
30 Days · Tout sèks · Mizajou Sep 16, 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ap rekriteFaz 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

Ap rekriteFaz 1/2
  • University of Chicago, Chicago
Laj 1 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Ap rekriteEtid obsèvasyon
  • The University of Chicago, Chicago
1 Day – 17 Years · Tout sèks · Mizajou Aug 14, 2026 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Ap rekriteFaz 1/2
  • Research Site, Chicago
Laj 12 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT07109219

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Ap rekrite
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Laj 15 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06446661

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • ak 2 plis
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Ap rekrite
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Laj 14 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT03932903

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Ap rekriteFaz 1
  • University of Chicago Medical Center, Chicago
Laj 18 a 39 · Tout sèks · Mizajou Jun 29, 2026 · NCT03571321

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Ap rekriteFaz 2
  • University of Chicago Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT04747912

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Lurie Children's Hospital-Chicago, Chicago
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Ap rekriteFaz 1
  • University of Chicago, Chicago
Laj 13 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Northwestern, Chicago
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Ap rekriteFaz 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Ap rekriteFaz 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Laj 18 a 54 · Tout sèks · Mizajou Mar 17, 2026 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Ap rekriteFaz 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Laj 1 a 40 · Tout sèks · Mizajou Mar 12, 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Leksemi limfoblastik egi nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.